{"organizations": [], "uuid": "ca7ba80386e8158bac320d79bd3a2fb898b9ec49", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180328.html", "section_title": "Archive News &amp; Video for Wednesday, 28 Mar 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-guangdong-hybribio-biotech-unit-re/brief-guangdong-hybribio-biotech-unit-receives-permission-of-clinical-trial-granted-by-china-fda-idUSL3N1RA5C1", "country": "US", "domain_rank": 408, "title": "BRIEF-Guangdong Hybribio Biotech ‍unit receives permission of clinical trial granted by China FDA", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.239, "site_type": "news", "published": "2018-03-28T21:50:00.000+03:00", "replies_count": 0, "uuid": "ca7ba80386e8158bac320d79bd3a2fb898b9ec49"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-guangdong-hybribio-biotech-unit-re/brief-guangdong-hybribio-biotech-unit-receives-permission-of-clinical-trial-granted-by-china-fda-idUSL3N1RA5C1", "ord_in_thread": 0, "title": "BRIEF-Guangdong Hybribio Biotech ‍unit receives permission of clinical trial granted by China FDA", "locations": [], "entities": {"persons": [], "locations": [{"name": "china", "sentiment": "none"}], "organizations": [{"name": "brief-guangdong hybribio biotech", "sentiment": "negative"}, {"name": "reuters) - guangdong hybribio biotech co ltd", "sentiment": "neutral"}, {"name": "beijing headline news", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "March 28 (Reuters) - Guangdong Hybribio Biotech Co Ltd :\n* Says its wholly owned unit received permission of clinical trial granted by China FDA with respect to Chloroquine Phosphate Gel\nSource text in Chinese: goo.gl/F9hnLQ\nFurther company coverage: (Beijing Headline News)\n ", "external_links": ["https://twitter.com/reuters", "https://www.youtube.com/user/ReutersVideo", "https://www.linkedin.com/company/10256858/", "https://www.facebook.com/Reuters", "https://www.thomsonreuters.com/en/privacy-statement.html", "http://thomsonreuters.com/en/about-us/trust-principles.html", "https://instagram.com/reuters/", "https://goo.gl/F9hnLQ"], "published": "2018-03-28T21:50:00.000+03:00", "crawled": "2018-03-29T15:36:25.014+03:00", "highlightTitle": ""}